AlphaYouOA
Insider buying
Orbimed Advisors Llc bought $10M of BlossomHill Therapeutics, Inc. (BLSM) stock
Orbimed Advisors Llc, Dir of BlossomHill Therapeutics, Inc. (BLSM), bought 625,000 shares of BLSM stock worth $10M, per an SEC Form 4 filed Aug 12, 2026.
The shares came through a private deal, not the open market.
The trade happened on Aug 10, 2026, 2 days before it was made public.
BLSM has moved +61.0% since the trade date, from $15.99 to $25.74 (Sep 18, 2026 close).
- Traded
- Aug 10, 2026
- Disclosed
- Aug 12, 2026
- Filing delay
- 2 days
- Price since
- +61.0%
- Role
- Dir
- Source
- SEC Form 4
More BLSM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.